Oxytocin (10 mg Vial) Dosage Protocol
Oxytocin is a 9-amino-acid hypothalamic neuropeptide involved in social bonding, lactation, and parturition. Studied for social-cognition effects and limited mood applications.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Route: Subcutaneous (or intranasal) | Frequency: Once daily | Half-life: ~3 minutes (CNS effects last hours)
Standard Approach (3 mL = 3.33 mg/mL)
Reconstituting with 3 mL bacteriostatic water produces a concentration of 3.33 mg/mL. Volume per dose changes with concentration; mg dose itself does not change between vial sizes.
| Phase / Protocol | Dose | U-100 Units | Volume | Doses per vial |
|---|---|---|---|---|
| Weeks 1–2 (titration) | 100 mcg | 3 units | 0.030 mL | 100 doses |
| Weeks 3–4 | 200 mcg | 6 units | 0.060 mL | 50 doses |
| Weeks 5–6 | 300 mcg | 9 units | 0.090 mL | 33 doses |
| Weeks 7–8 | 400 mcg | 12 units | 0.12 mL | 25 doses |
| Weeks 9–12 (target) | 500 mcg | 15 units | 0.15 mL | 20 doses |
Reconstitution Steps
- Wipe the vial stopper and BAC water vial with alcohol; let dry.
- Draw 3 mL of bacteriostatic water into a sterile syringe.
- Inject slowly down the inside glass wall of the peptide vial. Do not aim at the powder.
- Gently swirl until fully dissolved. Do not shake.
- Label with reconstitution date. Refrigerate at 2–8°C; use within 28 days.
Supplies Needed
Estimates for an 8-week and 12-week cycle at 300 mcg per dose, once daily (7 doses/week).
| Item | 8-Week Cycle | 12-Week Cycle |
|---|---|---|
| Oxytocin (10 mg) vials | 2 vials | 3 vials |
| Insulin syringes (U-100) | 56 | 84 |
| Bacteriostatic water (10 mL) | 1 × 10 mL | 1 × 10 mL |
| Alcohol swabs | 1 × 100-pack | 2 × 100-pack |
Protocol Overview
Oxytocin protocols are typically PRN (as-needed) rather than scheduled, given the short half-life and acute (minutes-to-hours) effect window. Most research uses intranasal route for CNS effects; subcutaneous works for systemic protocols.
Dosing Protocol
Daily titration (subcutaneous):
- Weeks 1–2 (titration): 100 mcg/day.
- Weeks 3–4: 200 mcg/day.
- Weeks 5–6: 300 mcg/day.
- Weeks 7–8: 400 mcg/day.
- Weeks 9–12 (target): 500 mcg/day.
Timing: Once daily; effects begin within 15–30 min and last 1–2 hours. Some protocols add a smaller PRN dose before specific social contexts.
Cycle: 12 weeks daily, then 4-week break.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 28 days, protect from light |
Important Notes
How This Works
Oxytocin is a 9-amino-acid neuropeptide synthesized in the supraoptic and paraventricular hypothalamic nuclei. It acts both peripherally (uterine contraction, milk ejection) and centrally (social-bonding, anxiolytic, and pair-bonding effects via amygdala and prefrontal pathways).
Potential Benefits & Side Effects
Potential Benefits
- Studied for social cognition and bonding effects.
- Anxiolytic in some social-anxiety models.
- Established clinical use in obstetrics (parturition / lactation).
Side Effect Profile
- Headache, flushing.
- Nasal irritation (intranasal route).
- Mood lability in some users.
- Can affect uterine tone — caution in pregnancy.
Lifestyle Factors
- Most research uses intranasal route for CNS effects.
- Effects are brief — timing matters relative to social context studied.
Injection Technique
- Subcutaneous, intranasal, or sublingual depending on protocol.
- Rotate injection sites if dosing sub-Q.